Introduction and objectives: In Uganda, there are over one million people with HIV/AIDS. When advanced, this disease is characterized by life-threatening opportunistic infections. As the formal health sector struggles to confront this epidemic, new medicines from traditional sources are needed to complement control efforts. This study was conducted to document herbal medicines used in the treatment of HIV/AIDS and related opportunistic infections, and to document the existing knowledge, attitudes and practices related to HIV/AIDS recognition, control and treatment in Sembabule, Kamuli, Kabale and Gulu districts in Uganda. Methods: In this study, 25 traditional medicine practitioners (TMPs) were interviewed using structured questionnaires. Results: The TMPs could recognize important signs and symptoms of HIV/AIDS and its associated opportunistic infections. The majority of practitioners treated patients who were already receiving allopathic medicines including antiretroviral drugs (ARVs) prescribed by allopathic practitioners.
Introduction
About one million Ugandans are infected with HIV, a predominantly sexually transmitted virus that targets the immune system (UNAIDS and WHO, 2008) . The advanced stage of the disease is known as the Acquired Immune Deficiency Syndrome (AIDS). Untreated, infected individuals develop profound suppression of the immune system and become susceptible to a wide range of infections (opportunistic infections) and certain malignancies. Consequently, the HIV/AIDS epidemic has dramatically increased the health needs of the Ugandan population, placing great demands on the formal health sector.
Life-long therapy with antiretroviral drugs (ARVs) is the only treatment with proven efficacy against HIV (Palella et al., 1998) . In recent years, free access to ARVs has increased in Uganda. However, as of 2008, it is estimated that less than 50% of the patients requiring ARVs were actually receiving treatment (UAC, 2007) . Moreover, most ARV treatment sites are located in towns and urban centres whereas access to treatment in rural areas remains disproportionately low.
Uganda has a diverse and rich medicinal plant resource relative to other parts of Africa (Davis et al., 1986) . Previous studies have identified numerous medicinal plants used for various diseases of public health significance such as malaria and tuberculosis in Uganda (Adjanohoun et al., 1993; Tabuti et al., 2003; Kokwaro, 1993) . However, traditional medicine (TM) practice remains largely unregulated and poorly integrated into the formal health sector, and there are scarce data on medicinal plants used for HIV/AIDS treatment (Yahaya et al., 2004) . Documentation of Ugandan TM is critical to safeguard indigenous knowledge and conserve medicinal plant species, both of which are rapidly being lost (Kingdon, 1990) . Importantly, documentation of TM can facilitate future research on the safety and efficacy of medicinal plants in the treatment of HIV/AIDS when used either alone or concurrently with ARVs.
The objectives of this study were to collect comprehensive data from traditional medicine practitioners (TMPs) on medicinal plants commonly used for HIV/AIDS treatment and to document the methods of preparation and administration of TM, in four rural districts of Uganda.
Methods
This survey employed an ethnobotanical approach comprising of TMP interviews in four Ugandan districts, Sembabule, Kamuli, Kabale and Gulu (Fig. 1) . The four districts are predominantly rural districts which were selected on the basis of cultural and geographic diversity.
Ethical approval for this study was obtained from the Uganda National Council of Science and Technology (registration number HS 410). Before interviewing any respondent, the study team members explained the objectives of the study, methods and the plans for use of the data that were to be generated from the interviews. Verbal consent to conduct the interviews was sought from every respondent before the interview and was granted in every case. In preparation for the survey, semi-structured questionnaires were developed to collect data on TMP demographics, knowledge on TM and TM treatment practices. These questionnaires were pretested in a pilot survey and subsequently refined. During the actual survey, one TMP in each district was identified based on their reputation and participation in previous ethnobotanical surveys. A snowball sampling approach was used to identify other TMPs in the respective district (Tongco, 2007; Bernard, 2002) . A few TMPs were identified by chance. Only TMPs who treated HIV/AIDS patients were included in the survey. A member of the study team served as an interpreter when necessary.
At the end of each interview, voucher specimens of plants mentioned by the interviewees were collected. The plants were identified by staff at Makerere University Herbarium (MHU) and named according to the Flora of Tropical East Africa (FTEA). Plant voucher specimens were processed and indexed as JRST and KCB and deposited at the MHU. The voucher specimens of commonly known plants were not indexed.
Clinical conditions treated in HIV/AIDS patients were coded using the Economic Botany Data Standard (www.kew.org/tdwguses). Questionnaire and botanical data were transferred into Excel ® spreadsheets for coding and preliminary analysis. The dataset was exported to SPSS ® statistical software Version 11.0 for Windows (SPSS Inc., Chicago, IL) for statistical analysis. The data were summarized in means and frequencies. Plant prioritization was based on frequency of use among TMPs and across districts. An Informant Consensus Factor (ICF) was calculated among the four study areas to determine the probability that respondents were using almost similar medicine plants (Albuquerque et al., 2006; Heinrich, 2000) . The ICF was estimated by computing the difference between the number of TMPs reporting use of TM in the treatment of HIV/AIDS (n TMP ) and number of taxa (n t ) mentioned per district divided by the number of TMPs (n TMP ) minus one. The following expression was used to calculate the ICF.
A high ICF (close to 1) suggests that the community is confident in the choice of plants, whereas a low ICF (close to 0) implies that the community is still experimenting and that the treatments may not be effective. In all cases, the calculated ICF was less than 0 and is not reported on further.
Results

Respondents' biographic details
We interviewed 25 TMPs, 10 from Kamuli district and five each from Sembabule, Gulu and Kabale districts. Nineteen of the interviewed TMPs were male. The median age (inter-quartile range) of respondents was 50 (43-58) years. Ten TMPs had attained postprimary formal education. Other demographic characteristics of TMPs across districts are shown in Table 1 .
Twenty-four TMPs attended to male and female patients and five TMPs treated pregnant women and children as well. TMPs estimated that they received on average 29 (range, 2-250) patients each year. Most TMPs (n = 18) received patients who were already on treatment with allopathic medicines and 10 respondents reported that they received patients who were already on ARVs from ARV treatment sites (Fig. 2) . The TMPs acquired knowledge about the treatment of HIV/AIDS from interaction with colleagues in the practice (n = 9), from their parents (n = 5) and through experimentation (n = 5). Other sources of knowledge acquisition mentioned included books and the press.
Knowledge about HIV/AIDS
The term commonly used to refer to HIV/AIDS is Slim (n = 19). Other local terms used include Munywenje (Runyakitara), Tuo jonyo (Acholi) and Mukenenya (Luganda). TMPs commonly identify HIV/AIDS by a skin rash, diarrhea and other symptoms or by reviewing patients HIV laboratory test results performed at allopathic medicine centres and laboratories (n = 8) ( Table 2 ). The majority of the TMPs reported that HIV is infectious and caused by unprotected sexual intercourse and the sharing sharp instruments with persons infected with HIV. However, two TMPs reported that HIV is transmitted by vectors (flies) from the wounds or fecal material of infected persons while one thought the delivery of twins resulted in HIV/AIDS. 
Treatment practices and plant species used by TMPs for HIV/AIDS patients
The TMPs mentioned 145 plant species in the study (Table 3) . Of these, 103 plant species belonging to 47 families were identified. The families Asteraceae (14%), Mimosaceae (9%) and Euphorbiaceae (7%) contributed the majority of the species. Five species mentioned by more than four or more TMPs in more than one district were prioritized as shown in Table 4 . One other specie, Psorospermum febrifugum was mentioned by five TMPs, but from one district. The parts of the plant most frequently used were the leaves, stem bark and the root bark (Fig. 3) . Specific HIV/AIDS-related conditions treated by TMPs using these medicinal plants are shown in Table 5 .
Medicine preparation, administration and storage
Commonly, decoctions of plant species were prepared using water or milk. The decoctions were mono-preparations (53.8%) or mixtures of multiple plant species (46.2%). A median of six (range, 2-20) plant species were used in the mixtures. Gulu and Kabale districts reported more mono-preparations compared to the other districts.
Most medicinal preparations (80%) were orally administered in variable doses. The other routes of administration included smearing ointments, tying crushed herbs on wounds and bathing. About half of the TMPs (n = 13) advised their patients to take the medicinal preparations after food while others gave no advice with regard to meals. Rituals were rarely used to accompany medicinal preparations for HIV/AIDS.
Medicinal preparations were commonly prepared in small portions and prescribed for short durations (about 2-3 days). For longer storage, TMPs reported using preservation methods including making of powders, adding rock salt, Azadirachta indica extracts or honey, drying and burning to make ash. The medicines were commonly packaged in plastic bottles (which were washed and re-used as necessary) and plastic bags. The TMPs assessed patient recovery by patient feedback. According to TMPs, 84% of their patients confirmed that their condition improved following the use of medicinal preparations. However, only 48% of the TMPs interviewed kept records indicating whether or not their patients had recovered and none of the TMPs used hospital laboratory tests to confirm recovery.
Discussion
Traditional knowledge of HIV/AIDS treatment
HIV/AIDS is a relatively new disease-first described in Uganda in 1985 (Serwadda et al., 1985) , and the practice of TM for HIV/AIDS does not appear to be well developed. Knowledge about HIV/AIDS treatment was acquired mainly from colleagues and by experimentation and there has been no opportunity for refinement of this process over generations.
In contrast to allopathic medicine-which makes the distinction between the treatment of HIV infection and the treatment of associated opportunistic infections, TMPs appeared to focus on the treatment of AIDS symptoms and opportunistic infections. This is expected because HIV infection may be asymptomatic for extended periods and patients are likely to seek treatment only at the later stages of the disease when AIDS-related symptoms and opportunistic infections occur.
Treatment practices and medicinal plants
Many plant species identified in this survey belonged to the families Asteraceae and Euphorbiaceae, which are well recognized for their medicinal value in Uganda (Hamill et al., 2000) . These plants are widely distributed in nature and chances of TMPs experimenting with them are high. The disagreement (or the very low ICF) in plants reported by different TMPs may be explained by the fact that TMPs treated the AIDS conditions and opportunistic infections rather than HIV infection per se. For example, Mangifera indica, Erythrina abyssinica, Warburgia salutaris and Eucalyptus sp.-which were identified in this survey, are medicinal plants recognized for treatment of coughs and some opportunistic infections in HIV/AIDS present with cough (Gautam et al., 2007; Hamill et al., 2000; Tabuti et al., 2010) . Alternative plants were used for treating patients presenting with other symptoms. Other factors which could have contributed to the low consensus include imperfect transfer of TM knowledge, diversity in cultural backgrounds of TMPs, high plant diversity in the study areas and declining knowledge of medicinal plants (Thomas et al., 2009) .
The underlying cause of the clinical disorders seen in HIV/AIDS patients is the progressive loss of CD4 positive T-cell lymphocytes in blood. These cells are important because they mediate immune responses and their depletion is associated with opportunistic infections (Kaslow et al., 1987) . In a pre-clinical study in Cuba, a stem bark extract of Mangifera indica was shown to prolong survival of T-cell lymphocytes by opposing T-cell activation-a significant mechanism for T-cell depletion in HIV/AIDS patients (Hernandez et al., 2006) . This finding suggests that Mangifera indica may have beneficial effects on the immune system of HIV/AIDS patients however, its role in actual patients remains to be established.
Knowledge on the efficacy and safety of the other priority plants is derived mainly from a few in vitro studies. A sequiterpenoid isolated from the extract of Warburgia salutaris has demonstrated antibacterial activity (Rabe and van Staden, 2000) and this characteristic may be useful for bacterial infections in HIV/AIDS patients. In contrast, the extract of Erythrina abyssinica lacks antibacterial activity, it however may be useful in the treatment of malaria which is co-endemic with HIV/AIDS in Uganda (Wagate et al., 2010; Yenesew et al., 2003) . The extract of Erythrina abyssinica should however be used with caution because it contains chalcones which are toxic to intestinal cells (Cui et al., 2008) .
This survey provides a first view of the wide range of medicinal plants used for treatment of HIV/AIDS patients in the study districts. Conservation of these medicinal plants is critical. Medicinal plants may yield novel compounds that may be of interest for drug development and some African medicinal plants have recently Fig. 3 . Distribution of plant parts used for medicines. (Klos et al., 2009) . Although the medicinal plants identified in this survey appeared to target opportunistic infections, the presence or absence of specific activity against HIV can only be established after appropriate in vitro studies. Record keeping among TMPs should also be improved upon to facilitate the verification of claims of the effectiveness of their preparations. We observed that TMPs frequently advised their patients to take TM with food. Food may reduce stomach irritations caused by TM. Also, food may increase absorption of TM (and potentially increase efficacy) or decrease absorption of TM (possibly to reduce sideeffects of potent agents). In addition, food may be given to increase blood glucose levels which may be reduced by some medicinal plants (Ojewole, 2004) . While food intake may be desired, it is important to note that food may not always be available to patients. The chronic debilitating nature of HIV/AIDS is such that patients may be unable to work for extended periods, leading to food insufficiency. In order to minimize risks arising from non-compliance to food recommendations, clarification of the role of food during administration of the different TM preparations is needed.
Unfortunately, TM packaging and storage methods do not comply with the proposed standards of the Ugandan regulatory authorities. Re-used plastic containers and plastic bags were used, raising concerns of possible contamination of the TM preparations. In order to improve on this practice, TMP sensitization and education on safe packaging and storage of TM preparations is needed.
Role of TM in Uganda's HIV/AIDS response
With increasing access to ARVs in Uganda, an important consideration is the potential for interactions between TM and ARVs when they are administered concurrently. Some classes of ARVs have great potential for unwanted herbal-drug interactions (Lee et al., 2006; Piscitelli et al., 2002) and some African medicinal plants have shown potential for unfavorable drug-herbal interactions with ARVs in laboratory studies (Brown et al., 2008; Mills et al., 2005) . Although it is recommended that clinicians collect information on TMs used by patients on ARVs (MOH, Jun 2009), patients may not know the actual medicinal plants being used or may underreport the use of TM during their ARV clinic visits. Ethnobotanical studies are therefore crucial to identify the panel of medicinal plants being used in order to facilitate pharmacologic studies to characterize the potential of these agents to affect the metabolism and activity of ARVs.
Nevertheless, positive roles have been identified for TM in Uganda's HIV/AIDS response. The Ugandan government highlights TM as a key resource for the expansion of prevention and treatment services for opportunistic infections (UAC, 2007) . This is because TMPs cater to health needs of the general community and are well positioned to provide primary health care services relevant to HIV/AIDS. In order to prevent the spread of HIV/AIDS to the community, public health officials should engage TMPs in order to equip the TMPs with the skills for disseminating prevention messages to their patients. Also, improved referral systems between TMPs and ARV clinics can increase HIV/AIDS testing and treatment efforts. Furthermore, research collaborations between TMPs may promote research and development of new treatments from medicinal plant sources. In order to take advantage of these opportunities, TMPs must be reassured that their intellectual property rights will be protected during collaborations with other stakeholders. An ongoing dialogue between the Ugandan government and TMP associations is therefore needed to share information on the safety of TM, potential for interactions with ARVs and to delineate the role of TMPs in the HIV/AIDS response.
Conclusion
Based on the findings of this survey, TM may have a role in Uganda's public health approach to HIV/AIDS control. Many medicinal plants identified in this survey that are used to manage the numerous ailments occurring in HIV/AIDS patients, need to have their value in the therapeutic management of HIV/AIDS-related opportunistic infections investigated.
by the Health Research Board of Ireland/Irish AID Global Health Research Awards grant awarded to Dr. Concepta Merry to study Neglected translational research to improve HIV outcomes in rural Africa (GHRA07/09). The Uganda national Council for Science and Technology (UNCST) is acknowledged for granting permission to conduct this study.
